Disease presentation of 1312 childhood-onset systemic lupus erythematosus: influence of ethnicity

Imagem de Miniatura
Arquivos
art_FIOROT_Disease_presentation_of_1312_childhoodonset_systemic_lupus_erythematosus_2019.PDF (255.85 KB)
Citações na Scopus
18
Tipo de produção
article
Data de publicação
2019
DOI
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Editora
SPRINGER LONDON LTD
Autores
ISLABAO, Aline G.
TERRERI, Maria T.
SAAD-MAGALHAES, Claudia
SAKAMOTO, Ana P.
Citação
CLINICAL RHEUMATOLOGY, v.38, n.10, p.2857-2863, 2019
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Objective To evaluate the influence of ethnicity in presentation of childhood-onset systemic lupus erythematosus (cSLE) patients. Methods This multicenter study included cSLE patients (American College of Rheumatology criteria) followed in 27 Pediatric Rheumatology services of Brazil. Ethnicities were classified in four groups according to the parents' and all four grandparents' self-reported ethnicity. The statistical analysis was performed using the Bonferroni's correction (p < 0.0027). Results According to ethnic groups, 1537 cSLE patients were classified in Caucasian (n = 786), African-Latin American (n = 526), Asian (n = 8), and others/unknown (n = 217). Comparisons between 1312 African-Latin American and Caucasian revealed similar median age at cSLE diagnosis [12.2(2.6-18) vs. 12.1(0.3-18) years, p = 0.234], time interval to diagnosis [0.25(0-12) vs. 0.3(0-10) years, p = 0.034], and SLEDAI-2K score [14(0-55) vs. 14(0-63), p = 0.781] in both groups. The mean number of diagnostic criteria according to SLICC (6.47 +/- 1.911 vs. 5.81 +/- 1.631, p < 0.0001) and frequencies of maculopapular lupus rash (8% vs. 3%, p < 0.0001), palate oral ulcers (17% vs. 11%, p = 0.001), tongue oral ulcers (4% vs. 1%, p = 0.001), and nonscarring alopecia (29% vs. 16%, p < 0.0001) were significantly higher in African-Latin American, whereas malar rash (45% vs. 58%, p < 0.0001) was more frequent in Caucasian. The presence of anti-phospholipid antibody (23% vs. 12%, p < 0.0001), low complement levels (58% vs. 41%, p < 0.0001), and isolated direct Coombs test (10% vs. 5%, p = 0.001) was also significantly higher in the former group. Conclusions Our study demonstrated that disease presentation severity of African-Latin American cSLE patients is comparable with Caucasian. Mucocutaneous manifestations and autoantibodies profile were the only distinctive features of the former group. The unique mixed background of Brazilian patients probably minimized race diversity spectrum of these patients.
Palavras-chave
Anti-phospholipid antibody, Childhood-onset systemic lupus erythematosus, Ethnicity, Race
URI
https://observatorio.fm.usp.br/handle/OPI/34297
Referências
  1. Bader-Meunier B, 2005, J PEDIATR-US, V146, P648, DOI 10.1016/j.jpeds.2004.12.045
  2. Bradby H, 2003, ETHNIC HEALTH, V8, P5, DOI 10.1080/13557850303555
  3. Carneiro-Sampaio M, 2008, J CLIN IMMUNOL, V28, pS34, DOI 10.1007/s10875-008-9187-2
  4. Gedalia A, 1999, J NATL MED ASSOC, V91, P497
  5. Gladman DD, 2002, J RHEUMATOL, V29, P288
  6. Gomes RC, 2016, ARTHRIT CARE RES, V68, P1736, DOI 10.1002/acr.22881
  7. Goulielmos GN, 2018, GENE, V668, P59, DOI 10.1016/j.gene.2018.05.041
  8. Hiraki LT, 2009, J RHEUMATOL, V36, P2539, DOI 10.3899/jrheum.081141
  9. Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928
  10. Korbet SM, 2007, J AM SOC NEPHROL, V18, P244, DOI 10.1681/ASN.2006090992
  11. Levy DM, 2013, ARTHRIT CARE RES, V65, P152, DOI 10.1002/acr.21779
  12. Lewandowski LB, 2017, LUPUS, V26, P186, DOI 10.1177/0961203316660625
  13. Lopes SRM, 2017, LUPUS, V26, P996, DOI 10.1177/0961203317690616
  14. Novak GV, 2018, LUPUS, V27, P1712, DOI 10.1177/0961203318787037
  15. Novak GV, 2017, AUTOIMMUN REV, V16, P132, DOI 10.1016/j.autrev.2016.12.004
  16. Petri M, 2012, ARTHRITIS RHEUM-US, V64, P2677, DOI 10.1002/art.34473
  17. Gomez LAR, 2008, LUPUS, V17, P596, DOI 10.1177/0961203307088006
  18. Sahin S, 2018, LUPUS, V27, P514, DOI 10.1177/0961203317747717
  19. Setoue DN, 2018, AUTOIMMUN REV, V17, P836, DOI 10.1016/j.autrev.2018.03.009
  20. Silva CA, 2012, ARTHRIT CARE RES, V64, P1787, DOI 10.1002/acr.21757
  21. Silva CA, 2016, EXPERT REV CLIN IMMU, V12, P907, DOI 10.1080/1744666X.2016.1195685
  22. Silva CA, 2016, EXPERT REV CLIN IMMU, V12, P301, DOI 10.1586/1744666X.2016.1123621
  23. Stojan G, 2018, CURR OPIN RHEUMATOL, V30, P144, DOI 10.1097/BOR.0000000000000480
  24. Valoes CCM, 2017, LUPUS, V26, P484, DOI 10.1177/0961203316676386
  25. Weening JJ, 2004, KIDNEY INT, V65, P521, DOI 10.1111/j.1523-1755.2004.00443.x

Coleções
Artigos e Materiais de Revistas Científicas - FM/MCM
Artigos e Materiais de Revistas Científicas - FM/MPE
Artigos e Materiais de Revistas Científicas - HC/ICHC
Artigos e Materiais de Revistas Científicas - HC/ICr
Artigos e Materiais de Revistas Científicas - LIM/17
Artigos e Materiais de Revistas Científicas - LIM/36